News About: Goverment
Pfizer Korea’s Neurotain import suspended
The Korea Food and Drug Administration announced Tuesday that it notified Pfizer Korea of its ruling to have Pfizer Korea suspend its importation for Neurotin (gabapentin) 600 mg tablets for one month (February 1-28) ...
Rules concerning manufacture of OTC drugs eased
In order to boost the sluggish production of over-the-counter drugs, an accelerated screening system will be introduced and their marketing will be allowed, provide that their safety and appropriate dosage are confirm...
KFDA approves new type 2 diabetic agent
The Korea Food and Drug Administration said Monday it has approved Onglyza (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor.
Developed by Bristol-Myers Squibb Company and AstraZeneca, Onglyza is indicated ...
KFDA to reveal all excipients of parenteral preparations
The Korea Foods and Drug Administration plans to disclose all excipients to be used in parenteral preparation and eye/ear drop as the component might affect the safety and efficacy of the finished product depending on...
HIRA discloses screening details of 44 treatments and tests
The Health Insurance Review Agency has revealed a total of 44 screening criteria for 44 treatments and tests to be reimbursed under health insurance scheme.
HIRA officials reiterated that the disclosure of such scr...
Pharmacists get angry over poor DUR system
A number of pharmacists in Seoul could not perform the dispensing business due to technical setbacks of the Drug Utilization Review (DUR) system last Saturday.
Pharmacists tried to perform the DUR program from 11 a...
Release of aseptic preparations to be shortened
Amino infusion makers will be able to release their products in an earlier period.
The Korea Food and Drug Administration says it will introduce a parametric release system, under which aseptic preparations could b...
Civic group to file petition over OTC sales in supermarkets
About 50 civic groups including Health and Welfare Assembly (HWA) are joining hands to press ahead with a campaign for the sale of over-the-counter drugs at convenient stores.
These groups will file a petition to t...
Cancer treatment fee showed 3.6-fold increase in six years
The national health insurance covered 2.9 trillion won for the treatment of 621,402 cancer patients, showing a 3.6-fold increase compared with 809.6 billion won in 2003.
The National Health Insurance Corp. said the...
Pharmacy to benefit from card firms’ no-interest program
The Ministry of Health and Welfare said Thursday that pharmacies could settle their transaction amount by a three-month installment method with no interest.
The ministry’s response came when the Korean Pharmaceutic...
